Samuel J. Reich - 13 Sep 2022 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Executive Chairman, Director
Signature
/s/ Samuel J. Reich
Issuer symbol
SABS
Transactions as of
13 Sep 2022
Net transactions value
$0
Form type
4
Filing time
15 Sep 2022, 17:15:15 UTC
Previous filing
23 May 2022
Next filing
02 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SABS Employee Stock Option (right to buy) Award $0 +525,000 $0.000000 525,000 13 Sep 2022 Common Stock 525,000 $0.7100 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
F2 The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter.